The Cigna Group (NYSE:CI) Shares Sold by Empowered Funds LLC

Empowered Funds LLC reduced its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 4.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 49,223 shares of the health services provider's stock after selling 2,404 shares during the period. Empowered Funds LLC's holdings in The Cigna Group were worth $17,053,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. grew its position in The Cigna Group by 8.1% in the 1st quarter. Vanguard Group Inc. now owns 26,793,138 shares of the health services provider's stock valued at $9,731,000,000 after buying an additional 2,017,333 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of The Cigna Group by 6.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 14,341,233 shares of the health services provider's stock worth $5,208,593,000 after acquiring an additional 867,180 shares during the period. AQR Capital Management LLC raised its holdings in The Cigna Group by 63.4% during the second quarter. AQR Capital Management LLC now owns 1,547,245 shares of the health services provider's stock worth $510,467,000 after purchasing an additional 600,215 shares in the last quarter. Swedbank AB acquired a new stake in The Cigna Group in the first quarter valued at about $161,300,000. Finally, Ameriprise Financial Inc. boosted its holdings in The Cigna Group by 23.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,138,193 shares of the health services provider's stock valued at $706,822,000 after purchasing an additional 405,694 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Trading Down 0.7 %

Shares of CI stock traded down $2.35 during mid-day trading on Friday, hitting $321.53. 1,650,169 shares of the company's stock were exchanged, compared to its average volume of 1,545,534. The stock has a market cap of $89.43 billion, a price-to-earnings ratio of 30.36, a PEG ratio of 1.00 and a beta of 0.51. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $370.83. The stock has a 50-day simple moving average of $339.52 and a two-hundred day simple moving average of $339.91.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same period in the previous year, the firm earned $6.77 earnings per share. The Cigna Group's revenue was up 29.8% compared to the same quarter last year. Equities analysts expect that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.74%. The Cigna Group's payout ratio is 52.83%.

Insider Buying and Selling

In other news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now owns 17,539 shares in the company, valued at $6,010,264.52. This trade represents a 13.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on CI. Stephens restated an "overweight" rating and issued a $410.00 price target on shares of The Cigna Group in a research note on Friday, November 1st. Royal Bank of Canada lowered their price target on shares of The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Barclays raised their price objective on shares of The Cigna Group from $405.00 to $420.00 and gave the company an "overweight" rating in a research note on Tuesday, November 5th. Jefferies Financial Group upped their target price on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a "buy" rating in a research report on Tuesday, September 17th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $400.00 price target on shares of The Cigna Group in a research report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $394.64.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.